Related Experiment Video
Updated: Jan 14, 2026
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
Multiplexed tumor-mimetic dECM-chip platform for colorectal cancer: Interrogating pharmacological synergy and NK cell
Yang Li1, Jia-Long Wang1, Li-Guo Liang2
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Abstract:
To address the heterogeneity and intractability of colorectal cancer (CRC), this study proposes a hypothesis that the development of an innovative organoid-on-a-chip platform, which combines the biochemical properties of the decellularized intestinal matrix (dECM)-hydrogel composite material with the dynamic regulation capability of microfluidic control, can achieve dual functions: drug toxicity analysis for CRC and evaluation of the killing effect of NK cell-derived exosomes. Experiments showed that the pore structure (50-150 μm) and mechanical properties of the 5 % GelMA-dECM scaffolds accurately matched the physiological conditions and supported the long-term culture of colorectal tumor-like organs. The killing effect of NK cell-derived exosomes in the 3D environment, compared to the 2D environment, revealed their targeting of hypoxic regions. This platform is closer to the dynamic microenvironment of colorectal tumor foci than the traditional 2D model, which can reduce the reliance on animal experiments and provide optimized conditions for personalized precision medicine. Finally, this hypothesis suggests the potential for simulating the immunomicroenvironmental, with implications for clinical applications.
Insights
A novel organoid-on-a-chip platform using decellularized intestinal matrix (dECM) hydrogels enhances colorectal cancer (CRC) drug toxicity analysis and natural killer (NK) cell exosome efficacy evaluation.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Tissue Engineering
Background:
- Colorectal cancer (CRC) presents significant heterogeneity and treatment challenges.
- Existing models often fail to replicate the complex tumor microenvironment.
Purpose of the Study:
- To develop an innovative organoid-on-a-chip platform for CRC research.
- To assess drug toxicity and natural killer (NK) cell-derived exosome efficacy.
- To create a more physiologically relevant model for personalized medicine.
Main Methods:
- Fabrication of a 5% GelMA-dECM hydrogel scaffold with specific pore sizes (50-150 μm).
- Utilizing microfluidic control to mimic dynamic physiological conditions.
- Culturing colorectal tumor-like organoids within the 3D scaffold.
- Comparing the efficacy of NK cell-derived exosomes in 2D versus 3D environments.
Main Results:
- The GelMA-dECM scaffolds exhibited mechanical properties and pore structures suitable for long-term organoid culture.
- NK cell-derived exosomes demonstrated enhanced killing effects in the 3D organoid-on-a-chip model, particularly targeting hypoxic regions.
- The platform closely mimics the dynamic colorectal tumor microenvironment.
Conclusions:
- The organoid-on-a-chip platform provides a superior model for evaluating CRC treatments compared to traditional 2D methods.
- This technology can reduce the need for animal testing and advance personalized precision medicine in CRC.
- The platform shows potential for simulating the tumor immunomicroenvironment for clinical applications.
